Synthesis units
About This Opportunity
Varsinais-Suomen hyvinvointialue Finland: Synteesiyksiköt. Supply contract, governance & public sector. Submission deadline Nov 2026.
This is a supplies contract in the health and medical services and general supplies sectors. Located in Finland, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before November 6, 2026.
Published through Hilma Finland, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This is an advance notice — the formal tender is expected to be published shortly. Interested parties can use this time to prepare documentation and identify potential partners.
Description
Auto-translated from fiSynthesis units The Clinical Physiology, Isotope, and PET Examinations unit's isotope department will move to new premises in May 2027 upon completion of the T-hospital extension. For the new isotope department, there is a need to procure synthesis units primarily for the in-house production of 177Lu-labeled radiopharmaceuticals. Two synthesis units are needed as part of the initial equipment.
The synthesis unit includes a lead-shielded Class III biological safety cabinet, inside which the synthesis device is installed. The procurement concerns two synthesis units, one of which will be used for the in-house production of 177LuPSMA-I&T and the other for 177Lu-octreotide radiopharmaceuticals. 177Lu-PSMA-I&T radiopharmaceutical is used for treating patients with castration-resistant prostate cancer, and 177Lu-octreotide for neuroendocrine tumors. In the future, significant cost savings will be achieved in these cancer treatments through the in-house production of radiopharmaceutical agents.
The design of the new isotope department premises has taken into account the synthesis units, including their width, height, and weight. The dimensions of the units are based on usability, cost-effectiveness, and adequate radiation protection. Designated installation locations have been reserved for the synthesis units in the cleanroom P1032, where the units must be installable without structural modifications. The load-bearing capacity of the cleanroom floor is designed for synthesis units weighing up to 1500 kg, and therefore, a weight limit of no more than 1,200 kg was set as an absolute requirement for the units. Furthermore, the unit must be installable in a cleanroom with an internal ceiling height of 2600 mm. Other absolute requirements for the equipment are defined in Annex 1 "Unit Specifications" of the decision.
Based on the EU-wide market survey conducted by the contracting authority, only Trasis S.A and the synthesis units supplied by Trasis S.A can meet the absolute requirements set by the contracting authority for the equipment.
The direct procurement is based on Section 40, Paragraph 2, Clause 2 of the Procurement Act, due to technical reasons or reasons related to the protection of exclusive rights, only a specific supplier can carry out the procurement; an additional condition is that there are no reasonable alternative or substitute solutions, and the lack of competition is not due to an artificial restriction of the procurement conditions.
The procurement includes two synthesis units and potential optional supplies, as well as maintenance services for the period after the warranty.
Lot 1: Synthesis units
The Clinical Physiology, Isotope, and PET Examinations unit's isotope department will move to new premises in May 2027 upon completion of the T-hospital extension. For the new isotope department, there is a need to procure synthesis units primarily for the in-house production of 177Lu-labeled radiopharmaceuticals. Two synthesis units are needed as part of the initial equipment.
The synthesis unit includes a lead-shielded Class III biological safety cabinet, inside which the synthesis device is installed. The procurement concerns two synthesis units, one of which will be used for the in-house production of 177LuPSMA-I&T and the other for 177Lu-octreotide radiopharmaceuticals. 177Lu-PSMA-I&T radiopharmaceutical is used for treating patients with castration-resistant prostate cancer, and 177Lu-octreotide for neuroendocrine tumors. In the future, significant cost savings will be achieved in these cancer treatments through the in-house production of radiopharmaceutical agents.
The design of the new isotope department premises has taken into account the synthesis units, including their width, height, and weight. The dimensions of the units are based on usability, cost-effectiveness, and adequate radiation protection. Designated installation locations have been reserved for the synthesis units in the cleanroom P1032, where the units must be installable without structural modifications. The load-bearing capacity of the cleanroom floor is designed for synthesis units weighing up to 1500 kg, and therefore, a weight limit of no more than 1,200 kg was set as an absolute requirement for the units. Furthermore, the unit must be installable in a cleanroom with an internal ceiling height of 2600 mm. Other absolute requirements for the equipment are defined in Annex 1 "Unit Specifications" of the decision.
Based on the EU-wide market survey conducted by the contracting authority, only Trasis S.A and the synthesis units supplied by Trasis S.A can meet the absolute requirements set by the contracting authority for the equipment.
The direct procurement is based on Section 40, Paragraph 2, Clause 2 of the Procurement Act, due to technical reasons or reasons related to the protection of exclusive rights, only a specific supplier can carry out the procurement; an additional condition is that there are no reasonable alternative or substitute solutions, and the lack of competition is not due to an artificial restriction of the procurement conditions.
The procurement includes two synthesis units and potential optional supplies, as well as maintenance services for the period after the warranty.
CPV: 33000000
Organisation: Varsinais-Suomen hyvinvointialue
Procedure: neg-wo-call
Data provenance
This notice is sourced from Hilma Finland and was originally published on May 6, 2026. Last refreshed 34 days ago. Original language: fi. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Varsinais-Suomen hyvinvointialue
Varsinais-Suomen hyvinvointialue has issued 232 procurement notices on BidsFactory, including 52 currently open and 103 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Construction & Civil Works. All notices are published for Finland. Notices are distributed via Hilma Finland and TED - Tenders Electronic Daily (EU). Most recent publication: June 29, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Where will the contract be performed?
The contract is for delivery in Finland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Hilma Finland to access the full notice, required documents, and submission instructions provided by the contracting authority.
When does this tender close?
The submission deadline is November 6, 2026. You have 129 days left to prepare and submit your proposal to the contracting authority.
Who is the contracting authority?
This notice was issued by Varsinais-Suomen hyvinvointialue in Finland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.